RXO (NYSE:RXO) Receives “Neutral” Rating from The Goldman Sachs Group

The Goldman Sachs Group reiterated their neutral rating on shares of RXO (NYSE:RXOFree Report) in a research note issued to investors on Monday, MarketBeat.com reports. The Goldman Sachs Group currently has a $29.00 price target on the stock.

RXO has been the topic of a number of other reports. Wells Fargo & Company restated an “equal weight” rating and issued a $31.00 target price on shares of RXO in a report on Monday, November 11th. Susquehanna lowered their price objective on RXO from $16.00 to $12.00 and set a “negative” rating for the company in a research note on Tuesday, November 12th. Benchmark reiterated a “hold” rating on shares of RXO in a report on Tuesday, October 15th. TD Cowen increased their price target on RXO from $23.00 to $28.00 and gave the company a “hold” rating in a report on Thursday, August 8th. Finally, Morgan Stanley lifted their price objective on shares of RXO from $19.00 to $26.00 and gave the stock an “equal weight” rating in a research note on Monday, August 12th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, RXO presently has a consensus rating of “Hold” and an average target price of $26.47.

Check Out Our Latest Stock Analysis on RXO

RXO Stock Performance

RXO opened at $27.12 on Monday. RXO has a 52 week low of $18.75 and a 52 week high of $32.82. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.33 and a quick ratio of 1.33. The firm has a 50-day simple moving average of $27.85 and a two-hundred day simple moving average of $26.19.

RXO (NYSE:RXOGet Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.01. RXO had a positive return on equity of 1.64% and a negative net margin of 6.81%. The company had revenue of $1.04 billion during the quarter, compared to analyst estimates of $956.19 million. During the same period in the prior year, the company earned $0.05 earnings per share. The firm’s revenue was up 6.6% on a year-over-year basis. Equities analysts predict that RXO will post 0.12 EPS for the current year.

Institutional Trading of RXO

Institutional investors and hedge funds have recently modified their holdings of the stock. Nomura Asset Management Co. Ltd. grew its stake in RXO by 68.7% in the third quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock worth $39,000 after purchasing an additional 570 shares in the last quarter. GAMMA Investing LLC grew its position in shares of RXO by 40.0% during the 3rd quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock worth $50,000 after buying an additional 510 shares in the last quarter. Allspring Global Investments Holdings LLC increased its stake in shares of RXO by 2,235.3% during the first quarter. Allspring Global Investments Holdings LLC now owns 3,643 shares of the company’s stock valued at $80,000 after buying an additional 3,487 shares during the period. Canada Pension Plan Investment Board bought a new stake in shares of RXO in the second quarter valued at about $112,000. Finally, KBC Group NV lifted its stake in RXO by 28.1% in the third quarter. KBC Group NV now owns 4,055 shares of the company’s stock worth $114,000 after acquiring an additional 890 shares during the period. Institutional investors own 92.73% of the company’s stock.

RXO Company Profile

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Articles

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.